Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes
Victoria E. R. Parker, Darren Robertson, Edmundo Erazo-Tapia, Bas Havekes, Esther Phielix, Marlies de Ligt, Kay H. M. Roumans, Julian Mevenkamp, Folke Sjoberg, Vera B. Schrauwen-Hinderling, Edvin Johansson, Yi-Ting Chang, Russell Esterline, Kenneth Smith, Daniel J. Wilkinson, Lars Hansen, Lars Johan · 2023
Read Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes by Victoria E. R. Parker, Darren Robertson, Edmundo Erazo-Tapia, Bas Havekes, Esther Phielix, Marlies de Ligt, Kay H. M. Roumans, Julian Mevenkamp, Folke Sjoberg, Vera B. Schrauwen-Hinderling, Edvin Johansson, Yi-Ting Chang, Russell Esterline, Kenneth Smith, Daniel J. Wilkinson, Lars Hansen, Lars Johan (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10730390.txt.
Description
Victoria Parker and a large team of colleagues run a phase 2 trial of cotadutide, a dual hormone drug. The trial is in people who are overweight or obese with type 2 diabetes, with focus on the liver. Cotadutide activates both GLP-1 and glucagon receptors; the glucagon arm was the open question. People in the trial got the drug, a placebo, or the GLP-1-only drug liraglutide.
Cotadutide emptied liver glycogen stores more than either of the other arms and reduced liver fat. That is exactly what glucagon action should do, since glucagon triggers glycogen breakdown. Tolerability matched earlier reports. The authors read the results as human proof that the drug's glucagon activity works in the liver. That supports its development for fatty liver disease, diabetes, and kidney disease.
Catalog record
| CREATOR | Victoria E. R. Parker, Darren Robertson, Edmundo Erazo-Tapia, Bas Havekes, Esther Phielix, Marlies de Ligt, Kay H. M. Roumans, Julian Mevenkamp, Folke Sjoberg, Vera B. Schrauwen-Hinderling, Edvin Johansson, Yi-Ting Chang, Russell Esterline, Kenneth Smith, Daniel J. Wilkinson, Lars Hansen, Lars Johan |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |